- Home
- GSUN vs CYCN Comparison
GSUN vs CYCN Comparison
Compare GSUN & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSUN
- CYCN
- Stock Information
- Founded
- GSUN 1997
- CYCN 2018
- Country
- GSUN China
- CYCN United States
- Employees
- GSUN N/A
- CYCN N/A
- Industry
- GSUN Other Consumer Services
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- GSUN Real Estate
- CYCN Health Care
- Exchange
- GSUN Nasdaq
- CYCN Nasdaq
- Market Cap
- GSUN 6.4M
- CYCN 6.5M
- IPO Year
- GSUN 2022
- CYCN N/A
- Fundamental
- Price
- GSUN $2.38
- CYCN $2.81
- Analyst Decision
- GSUN
- CYCN
- Analyst Count
- GSUN 0
- CYCN 0
- Target Price
- GSUN N/A
- CYCN N/A
- AVG Volume (30 Days)
- GSUN 60.6K
- CYCN 21.8K
- Earning Date
- GSUN 08-01-2025
- CYCN 08-06-2025
- Dividend Yield
- GSUN N/A
- CYCN N/A
- EPS Growth
- GSUN N/A
- CYCN N/A
- EPS
- GSUN N/A
- CYCN N/A
- Revenue
- GSUN $10,159,020.00
- CYCN $2,081,000.00
- Revenue This Year
- GSUN N/A
- CYCN N/A
- Revenue Next Year
- GSUN N/A
- CYCN N/A
- P/E Ratio
- GSUN N/A
- CYCN N/A
- Revenue Growth
- GSUN 65.04
- CYCN N/A
- 52 Week Low
- GSUN $2.23
- CYCN $1.27
- 52 Week High
- GSUN $8.94
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- GSUN 26.08
- CYCN 41.24
- Support Level
- GSUN $2.50
- CYCN $3.02
- Resistance Level
- GSUN $2.88
- CYCN $3.16
- Average True Range (ATR)
- GSUN 0.12
- CYCN 0.21
- MACD
- GSUN -0.07
- CYCN -0.03
- Stochastic Oscillator
- GSUN 15.43
- CYCN 16.26
About GSUN Golden Sun Education Group Limited
Golden Sun Health Technology Group Ltd is a holding company. Along with its subsidiaries, it is engaged in the provision of education services and e-commerce business in the People's Republic of China. It offers tutorial centers for children and adults, one educational company that partners with high schools to offer language classes to their students, and one logistics company that provides logistics and consulting services. It has also established its wellness brands and an e-commerce platform to promote and sell wellness products. The company operates in the following segments; Education, which generates maximum revenue, and E-commerce.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.